The South African Competition Tribunal approves conditionally large merger on the market for infant-nutrition products (Nestlé / Pfizer)

S.A. Clears 3-to-2 Infant Nutrition Merger with Remedies* The South African Competition Tribunal has green-lighted the almost $12bn (R106bn) Nestlé/Pfizer deal, which will combine the largest and 3rd-largest infant-nutrition companies in the South African republic, leaving competitor Aspen in second

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Andreas Stargard, The South African Competition Tribunal approves conditionally large merger on the market for infant-nutrition products (Nestlé / Pfizer), 11 February 2013, e-Competitions Bulletin February 2013, Art. N° 61393

Visites 88

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues